Scripps' Nieva and the PARC group have applied for a National Institutes of Health grant to fund the screening of more patients.

FORBES: On The Cover/Top Stories

Jorge Nieva, the director of translational research at Scripps Cancer Center.

FORBES: Scanning For Cancer

The Scripps-PARC system may be able to determine whether chemotherapy is working and could indicate when a patient is on the wrong kind of chemo, says Nieva.

FORBES: On The Cover/Top Stories